Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AS-1763 by Carna Biosciences for Follicular Lymphoma: Likelihood of Approval
AS-1763 is under clinical development by Carna Biosciences and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
AS-1763 by Carna Biosciences for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
AS-1763 is under clinical development by Carna Biosciences and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData,...
AS-1763 by Carna Biosciences for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
AS-1763 is under clinical development by Carna Biosciences and currently in Phase I for Chronic Lymphocytic Leukemia (CLL). According to...
AS-1763 by Carna Biosciences for Lymphoma: Likelihood of Approval
AS-1763 is under clinical development by Carna Biosciences and currently in Phase I for Lymphoma. According to GlobalData, Phase I...